K
Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
TSX:GUD
Price:
5.77 CAD
Market Closed
Updated:
May 2, 2024
Knight Therapeutics Inc
Cash from Financing Activities
|
Knight Therapeutics Inc
Cash from Financing Activities Peer Comparison
Comparables:
BHC
WEED
CRON
C
CURA
T
TER
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Financing Activities
-CA$81m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Financing Activities
$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Financing Activities
-CA$347.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Financing Activities
-$1m
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash from Financing Activities
-$22.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Cash from Financing Activities
$10.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Knight Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
-81m
CAD
-81m
CAD
Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Cash from Financing Activities amounts to -81m CAD.
What is Knight Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-40%
-40%
Over the last year, the Cash from Financing Activities growth was -2 838%. The average annual Cash from Financing Activities growth rates for Knight Therapeutics Inc have been -40% over the past three years .
You don't have any saved screeners yet
